HOB Biotech Group (SHSE:688656) ROCE % : 9.85% (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is HOB Biotech Group ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. HOB Biotech Group's annualized ROCE % for the quarter that ended in Jun. 2024 was 9.85%.

HOB Biotech Group ROCE % Historical Data

The historical data trend for HOB Biotech Group's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HOB Biotech Group ROCE % Chart

HOB Biotech Group Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

48.99

33.56

19.70

6.17

7.37

HOB Biotech Group Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
ROCE %	Get a 7-Day Free Trial															9.96	9.86	6.65	2.12	9.85

HOB Biotech Group ROCE % Calculation

HOB Biotech Group's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	59.151	/	( ( (944.489 - 152.86)	+	(949.257 - 135.752) )	/ 2 )
	=	59.151	/	( (791.629	+	813.505)	/ 2 )
	=	59.151	/	802.567
	=	7.37 %

HOB Biotech Group's ROCE % of for the quarter that ended in Jun. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2024 )		(Q: Mar. 2024 )		(Q: Jun. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2024 )		(Q: Mar. 2024 )		(Q: Jun. 2024 )
	=	79.652	/	( ( (977.993 - 157.59)	+	(987.277 - 190.066) )	/ 2 )
	=	79.652	/	( ( 820.403	+	797.211 )	/ 2 )
	=	79.652	/	808.807
	=	9.85 %

(1) Note: The EBIT data used here is four times the quarterly (Jun. 2024) EBIT data.

HOB Biotech Group (SHSE:688656) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

HOB Biotech Group ROCE % Related Terms

Thank you for viewing the detailed overview of HOB Biotech Group's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

HOB Biotech Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » HOB Biotech Group Corp Ltd (SHSE:688656) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 218 Xinghu Road, Suzhou Industrial Park, C10 Building, Jiangsu, Suzhou, CHN, 215123

Website

http://www.hob-biotech.com

HOB Biotech Group Corp Ltd is an in vitro diagnostic company. The firm is specialized in providing diagnostic tools to laboratories and hospitals for the improvement of allergy and autoimmune disease patient care.

HOB Biotech Group Headlines

No Headlines